Insulet Announces CFO Transition : vimarsana.com

Reaffirms Guidance for Third Quarter and Fiscal Year 2023ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Wayde McMillan has decided to step down from his role as...

Related Keywords

Boston College , Massachusetts , United States , Acton , University Of Massachusetts , Angela Geryak Wiczek , Jim Hollingshead , Wayde Mcmillan , Deborahr Gordon , Lauren Budden , Insulet Corporation , Corporate Communications , Exchange Commission On , Master Of Business Administration , Gulf Oil , Medtronic , Pricewaterhousecoopers , Analysis For Medtronic Minimally Invasive Therapies Group , Exchange Commission , Health Care , Group Vice , Reaffirms Guidance , Third Quarter , Fiscal Year , Executive Vice President , Chief Financial Officer , Group Vice President , Chief Accounting Officer , Chief Executive , Total Omnipod , Total Company , Vice President , Financial Planning , Minimally Invasive Therapies Group , External Reporting , Business Administration , Certified Public , Omnipod Insulin Management System , Insulin Delivery System , Looking Statement , Annual Report , Investor Relations ,